Literature DB >> 9279251

CD4-positive T-lymphocytes infiltrate the bronchial mucosa of patients with Sjögren's syndrome.

S A Papiris1, M Saetta, G Turato, R La Corte, L Trevisani, C E Mapp, P Maestrelli, L M Fabbri, A Potena.   

Abstract

To investigate the degree and the type of inflammation in the bronchial mucosa in patients with Sjögren's syndrome, we examined lobar bronchial biopsies obtained from 10 patients with Sjögren's syndrome (six with primary and four with secondary) and eight control subjects. Histochemistry with hematoxylin-eosin was performed both to identify the number of mononuclear cells and eosinophils and to measure the thickness of the basement membrane. Immunohistochemistry was performed to identify neutrophils (neutrophil-elastase), macrophages (CD68), and T-lymphocyte subpopulations (CD4 and CD8) in the submucosa. Subjects with Sjögren's syndrome presented a greater number of CD4-positive T-lymphocytes than did the normal control subjects (p = 0.0129). Instead, eosinophils, neutrophils, macrophages, CD8 positive T-lymphocytes, and basement membrane thickness were similar in the two groups. There were no differences in cell counts between patients with primary and those with secondary Sjögren's syndrome and between symptomatic and asymptomatic patients. No correlation was found between cell counts, symptoms, lung volumes, and disease duration. This study has shown that patients with Sjögren's syndrome have an increased number of CD4 positive T-lymphocytes in the bronchial mucosa outside of the bronchial glands, supporting the concept that, in the airways. Sjögren's syndrome involves also extraglandular tissues.

Entities:  

Mesh:

Year:  1997        PMID: 9279251     DOI: 10.1164/ajrccm.156.2.9610076

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  10 in total

1.  Lymphocytic alveolitis: A surprising index of poor prognosis in patients with primary Sjogren's syndrome.

Authors:  Y A Dalavanga; P V Voulgari; A N Georgiadis; C Leontaridi; S Katsenos; M Vassiliou; A A Drosos; S H Constantopoulos
Journal:  Rheumatol Int       Date:  2005-12-13       Impact factor: 2.631

2.  Cryptogenic organizing pneumonia associated with primary Sjogren's syndrome.

Authors:  Savvas Ioannou; Sophie P Toya; Periklis Tomos; George E Tzelepis
Journal:  Rheumatol Int       Date:  2008-04-01       Impact factor: 2.631

3.  Defective selection of thymic regulatory T cells accompanies autoimmunity and pulmonary infiltrates in Tcra-deficient mice double transgenic for human La/Sjögren's syndrome-B and human La-specific TCR.

Authors:  Jane C Yaciuk; Yujun Pan; Karen Schwarz; Zi-Jian Pan; Jacen S Maier-Moore; Stanley D Kosanke; Christina Lawrence; A Darise Farris
Journal:  J Immunol       Date:  2015-01-12       Impact factor: 5.422

4.  Sjogren's Syndrome and Pulmonary Disease.

Authors:  Ruben A Peredo; Scott Beegle
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 5.  Pulmonary manifestations of Sjögren's syndrome.

Authors:  George Stojan; Alan N Baer; Sonye K Danoff
Journal:  Curr Allergy Asthma Rep       Date:  2013-08       Impact factor: 4.806

6.  Sicca Symptoms and their Association with Chronic Rhinosinusitis in a Community Sample.

Authors:  S Lester; M Rischmueller; Lw Tan; Pj Wormald; P Zalewski; Ma Hamilton-Bruce; S Appleton; Rj Adams; Cl Hill
Journal:  Open Rheumatol J       Date:  2012-06-28

7.  Risk of asthma in patients with primary Sjögren's syndrome: a retrospective cohort study.

Authors:  Te-Chun Shen; Hsuan-Ju Chen; Chang-Ching Wei; Chia-Hung Chen; Chih-Yen Tu; Te-Chun Hsia; Chuen-Ming Shih; Wu-Huei Hsu; Fung-Chang Sung; Da-Tian Bau
Journal:  BMC Pulm Med       Date:  2016-11-16       Impact factor: 3.317

8.  Pulmonary Involvement in a Mouse Model of Sjögren's Syndrome Induced by STING Activation.

Authors:  Joanna Papinska; Harini Bagavant; Grzegorz B Gmyrek; Umesh S Deshmukh
Journal:  Int J Mol Sci       Date:  2020-06-25       Impact factor: 5.923

Review 9.  Pulmonary Manifestations of Primary Sjögren's Syndrome: Underlying Immunological Mechanisms, Clinical Presentation, and Management.

Authors:  Sarthak Gupta; Marcela A Ferrada; Sarfaraz A Hasni
Journal:  Front Immunol       Date:  2019-06-12       Impact factor: 7.561

Review 10.  Pharmacological Interventions for Pulmonary Involvement in Rheumatic Diseases.

Authors:  Eun Ha Kang; Yeong Wook Song
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.